ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

KRYS Krystal Biotech Inc

161,10
0,87 (0,54%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Krystal Biotech Inc KRYS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,87 0,54% 161,10 06:00:15
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
163,55 157,895 164,74 161,10 160,23
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202413:00GLOBEKrystal Biotech to Present at the Association for Research..
26.4.202413:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
22.4.202413:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
04.4.202413:00GLOBEKrystal Biotech to Present at the American Association..
02.3.202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202413:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
26.2.202419:35EDGAR2Form 144 - Report of proposed sale of securities
26.2.202414:04EDGAR2Form 8-K - Current report
26.2.202414:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
26.2.202413:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
26.2.202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26.2.202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
20.2.202413:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
13.2.202413:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
08.2.202413:00GLOBEKrystal Biotech Announces Publication in the New England..
01.2.202413:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
24.1.202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202417:43EDGAR2Form 144 - Report of proposed sale of securities
04.1.202413:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
19.12.202313:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
27.11.202313:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
09.11.202313:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
06.11.202313:10EDGAR2Form 8-K - Current report
06.11.202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202313:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
30.10.202312:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
02.10.202318:07EDGAR2Form 144 - Report of proposed sale of securities
28.9.202313:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
07.9.202313:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
05.9.202313:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
21.8.202323:30EDGAR2Form 144 - Report of proposed sale of securities
16.8.202322:57EDGAR2Form 144 - Report of proposed sale of securities
15.8.202322:56EDGAR2Form 144 - Report of proposed sale of securities
11.8.202322:39EDGAR2Form 144 - Report of proposed sale of securities
11.8.202300:06EDGAR2Form 144 - Report of proposed sale of securities
07.8.202314:18EDGAR2Form 8-K - Current report
07.8.202313:13EDGAR2Form 8-K - Current report
07.8.202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202313:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
26.7.202322:14GLOBEKrystal Biotech Announces Pipeline Expansion into Oncology..
26.7.202322:01EDGAR2Form 8-K - Current report
18.7.202322:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10.7.202322:01GLOBEArbutus Appoints Two New Executives
03.7.202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202313:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
05.6.202313:00GLOBEKrystal Biotech to Present at Upcoming Investor Conferences

Kürzlich von Ihnen besucht

Delayed Upgrade Clock